KR900011762A - 1-헤테로아릴-3-아실-2-옥스인돌 소염제 - Google Patents

1-헤테로아릴-3-아실-2-옥스인돌 소염제

Info

Publication number
KR900011762A
KR900011762A KR1019900000165A KR900000165A KR900011762A KR 900011762 A KR900011762 A KR 900011762A KR 1019900000165 A KR1019900000165 A KR 1019900000165A KR 900000165 A KR900000165 A KR 900000165A KR 900011762 A KR900011762 A KR 900011762A
Authority
KR
South Korea
Prior art keywords
heteroaryl
acyl
oxindole
inflammatory agent
alkyl
Prior art date
Application number
KR1019900000165A
Other languages
English (en)
Other versions
KR920006785B1 (ko
Inventor
마르펫 안토니
Original Assignee
화이자 인코포코레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 화이자 인코포코레이티드 filed Critical 화이자 인코포코레이티드
Publication of KR900011762A publication Critical patent/KR900011762A/ko
Application granted granted Critical
Publication of KR920006785B1 publication Critical patent/KR920006785B1/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
KR1019900000165A 1989-01-10 1990-01-09 1-헤테로아릴-3-아실-2-옥스인돌 소염제 KR920006785B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
USPCT/US89/00079 1989-01-10
PCT/US1989/000079 WO1990008145A1 (en) 1989-01-10 1989-01-10 Anti-inflammatory 1-heteroaryl-3-acyl-2-oxindoles

Publications (2)

Publication Number Publication Date
KR900011762A true KR900011762A (ko) 1990-08-02
KR920006785B1 KR920006785B1 (ko) 1992-08-17

Family

ID=22214772

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900000165A KR920006785B1 (ko) 1989-01-10 1990-01-09 1-헤테로아릴-3-아실-2-옥스인돌 소염제

Country Status (18)

Country Link
EP (1) EP0378358B1 (ko)
JP (1) JPH0692400B2 (ko)
KR (1) KR920006785B1 (ko)
AT (1) ATE96793T1 (ko)
AU (1) AU616336B2 (ko)
CA (1) CA2007655C (ko)
DE (1) DE69004272T2 (ko)
DK (1) DK0378358T3 (ko)
ES (1) ES2060007T3 (ko)
FI (1) FI92827C (ko)
HU (1) HU215112B (ko)
IE (1) IE62143B1 (ko)
IL (1) IL92962A (ko)
NO (1) NO179103C (ko)
NZ (1) NZ232039A (ko)
PT (1) PT92800B (ko)
WO (1) WO1990008145A1 (ko)
ZA (1) ZA90139B (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2886541A1 (en) 2013-12-19 2015-06-24 Sanofi Oxindole derivatives, preparation thereof and therapeutic use in the treatment of AMPK-related diseases
CN108456205B (zh) * 2018-05-21 2021-06-04 深圳市众康动保科技有限公司 一种3,3二取代羟基吲哚化合物的合成方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4053613A (en) * 1975-09-17 1977-10-11 E. R. Squibb & Sons, Inc. 1,3,thiazolinyl and 1,3 thiazinyl substituted indolinones
US4721712A (en) * 1984-06-12 1988-01-26 Pfizer Inc. 1,3-disubstituted 2-oxindoles as analgesic and anti-inflammatory agents
DE3582890D1 (de) * 1984-02-07 1991-06-20 Pfizer 2-oxindolzwischenprodukte.
IN163263B (ko) * 1984-02-07 1988-08-27 Pfizer
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
US4569942A (en) * 1984-05-04 1986-02-11 Pfizer Inc. N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents
HU203350B (en) * 1984-08-24 1991-07-29 Pfizer Process for producing antiinflammatory tricyclic oxindole derivatives
US4690943A (en) * 1984-09-19 1987-09-01 Pfizer Inc. Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds
US4686224A (en) * 1984-10-31 1987-08-11 Pfizer Inc. Oxindole antiinflammatory agents
US4752609A (en) * 1985-06-20 1988-06-21 Pfizer Inc. Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds

Also Published As

Publication number Publication date
EP0378358B1 (en) 1993-11-03
NO912694D0 (no) 1991-07-09
IE62143B1 (en) 1994-12-14
ATE96793T1 (de) 1993-11-15
EP0378358A1 (en) 1990-07-18
FI92827C (fi) 1995-01-10
IL92962A (en) 1995-01-24
WO1990008145A1 (en) 1990-07-26
DE69004272T2 (de) 1994-02-24
DE69004272D1 (de) 1993-12-09
JPH02270868A (ja) 1990-11-05
ZA90139B (en) 1991-08-28
PT92800A (pt) 1990-07-31
AU4781690A (en) 1990-07-19
HUT62292A (en) 1993-04-28
NO179103C (no) 1996-08-07
HU215112B (hu) 1998-12-28
PT92800B (pt) 1995-12-29
CA2007655A1 (en) 1991-07-12
IE900075L (en) 1990-07-10
FI92827B (fi) 1994-09-30
AU616336B2 (en) 1991-10-24
JPH0692400B2 (ja) 1994-11-16
NZ232039A (en) 1991-07-26
KR920006785B1 (ko) 1992-08-17
ES2060007T3 (es) 1994-11-16
NO179103B (no) 1996-04-29
NO912694L (no) 1991-07-09
DK0378358T3 (da) 1993-12-06
CA2007655C (en) 1996-10-22
FI913324A0 (fi) 1991-07-09

Similar Documents

Publication Publication Date Title
AU2910600A (en) Phenyl urea and phenyl thiourea derivatives
FI952680A0 (fi) Injektoitavia taksaanijohdannaisiin pohjautuvia koostumuksia
ATE270103T1 (de) Aminophenoxyessigsäure derivate als neuroschützende mittel
CO5040088A1 (es) Nuevos compuestos y usos anestesicos locales
DK1042319T3 (da) Dihydrobenzofuraner
KR900011762A (ko) 1-헤테로아릴-3-아실-2-옥스인돌 소염제
AR020950A1 (es) Compuestos de 3-(fenil sustituido)-5-tienil-1,2,4-triazolo con actividad contra la mosca blanca
BR9612196A (pt) Tiazolinas substituidas
DK0378357T3 (da) Antiinflammatoriske 1-heteroaryl-oxindol-3-carboxamider
EP0365194A3 (en) Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides
ATE263560T1 (de) Neue verwendung von citreamicinen
DE69332232D1 (de) Immunsuppressive Enpyranosederivate
GB9512005D0 (en) Slip casting
MX9706627A (es) Derivado de tiazolidinona opticamente activo.
KR927003511A (ko) 5-리폭시게나제 억제제로서의 2-아릴메틸-1-나프톨 유도체의 에스테르
TW366344B (en) Endothelin antagonistic heteroaromatic ring-fused cyclopentene derivatives and pharmaceutical composition using the same
NO934399L (no) Tioesterderivater av 3'-O-propargyl-trifluortymidin, fremgangsmåte for fremstilling samt anvendelse av slike

Legal Events

Date Code Title Description
A201 Request for examination
E601 Decision to refuse application
E902 Notification of reason for refusal
J2X1 Appeal (before the patent court)

Free format text: APPEAL AGAINST DECISION TO DECLINE REFUSAL

G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20030711

Year of fee payment: 12

LAPS Lapse due to unpaid annual fee